Literature DB >> 6137295

Plasma somatostatin increases during hypoglycaemia in insulin-dependent patients with and without B-cell function.

S Madsbad, J Hilsted, T Krarup, B Tronier, L Sestoft.   

Abstract

Responses of somatostatin-like immunoreactivity (SLI) to hypoglycaemia were investigated in seven type 1 (insulin-dependent) patients with residual B-cell function, eight patients without B-cell function, and six healthy controls. A higher basal level of SLI was found in the group with B-cell function when compared with the group without B-cell function. The basal level in the normal subjects was in between the two diabetic groups. All the diabetics had a somatostatin response to hypoglycaemia which was independent of residual B-cell function and no different from that of normal subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137295     DOI: 10.1111/j.1365-2265.1983.tb00741.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.

Authors:  Erwan Leclair; Richard T Liggins; Ashley J Peckett; Trevor Teich; David H Coy; Mladen Vranic; Michael C Riddell
Journal:  Diabetologia       Date:  2016-04-13       Impact factor: 10.122

2.  Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.

Authors:  Jessica T Y Yue; Michael C Riddell; Elena Burdett; David H Coy; Suad Efendic; Mladen Vranic
Journal:  Diabetes       Date:  2013-02-22       Impact factor: 9.461

3.  Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center.

Authors:  Olivia L Butler; Monica M Mekhael; Arslan Ahmed; Daniel J Cuthbertson; D Mark Pritchard
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-16       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.